AMAG Pharmaceuticals ROCE
Cos'è ROCE di AMAG Pharmaceuticals?
ROCE di AMAG Pharmaceuticals, Inc. è -35.20%
Qual è la definizione di ROCE?
Il ritorno sul capitale investito (ROCE) è un rapporto finanziario che misura la redditività di un'azienda e l'efficienza con cui viene utilizzato il suo capitale.
Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders' equity and debt liabilities. It can be simplified as total assets minus current liabilities.
ROCE is especially useful when comparing the performance of companies in capital-intensive sectors. ROCE considers debt and other liabilities as well compared to other fundamentals which only analyze profitability related to a company’s common equity. This provides a better indication of financial performance for companies with significant debt. For a company, the ROCE trend over the years is also an important indicator of performance. In general, investors tend to favor companies with stable and rising ROCE numbers over companies where ROCE is volatile and bounces around from one year to the next.
Instead of using capital employed at an arbitrary point in time, analysts and investors often calculate ROCE based on the average capital employed (ROACE), which takes the average of opening and closing capital employed for the time period.
ROCE di aziende nel Health Care settore su NASDAQ rispetto a AMAG Pharmaceuticals
Cosa fa AMAG Pharmaceuticals?
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. Its products include Intrarosa, Vyleesi, Makena, CBR, Feraheme, and MuGard. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.
Aziende con roce simili a AMAG Pharmaceuticals
- Regulus Therapeutics Inc ha ROCE di -35.40%
- Clover Health Investments Corp ha ROCE di -35.37%
- Rosetta Stone ha ROCE di -35.37%
- Immutep ha ROCE di -35.34%
- Immutep ha ROCE di -35.34%
- FT AlphaDEX Canadian Dividend ETF Comm ha ROCE di -35.31%
- AMAG Pharmaceuticals ha ROCE di -35.20%
- GoldHaven Resources ha ROCE di -35.19%
- Armada Metals Ltd ha ROCE di -35.18%
- Zedge Inc ha ROCE di -35.11%
- Aurinia Pharmaceuticals Inc ha ROCE di -35.07%
- Purple Innovation Inc ha ROCE di -34.98%
- Arizona Metals ha ROCE di -34.96%